FDA tags psilocybin drug as clinical depression Breakthrough Therapy

Submitted by admin on December 2, 2019 - 9:46am

Source:

Pharmaforum

News Tags:

FDA

psilocybin

major depressive disorder

Usona

PSIL201

Headline:

FDA tags psilocybin drug as clinical depression Breakthrough Therapy

snippet:

The FDA has tagged psilocybin, the illegal psychoactive compound found in ‘magic mushrooms’, as a potential breakthrough treatment for major depressive disorder.

Search form

You are here

FDA tags psilocybin drug as clinical depression Breakthrough Therapy

FDA tags psilocybin drug as clinical depression Breakthrough Therapy